• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白低值和肝癌风险升高,来自 2 型糖尿病患者的研究。

Lower alpha fetoprotein and higher risk of hepatocellular carcinoma, study from the type 2 diabetes mellitus patients.

机构信息

Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

出版信息

Diabetes Res Clin Pract. 2018 Sep;143:239-244. doi: 10.1016/j.diabres.2018.07.018. Epub 2018 Jul 31.

DOI:10.1016/j.diabres.2018.07.018
PMID:30009939
Abstract

AIMS

To explore the association of type 2 diabetes mellitus (T2DM) with hepatocellular carcinoma (HCC) and alpha fetoprotein (AFP).

METHODS

750 patients with T2DM (T2DM group), 800 healthy people (control group) and 501 patients newly diagnosed with HCC were recruited from 2010 to 2016. The HCC patients were further divided into a HCC with T2DM (HCC+DM) group and a HCC without diabetes mellitus (HCC+NDM) group.

RESULTS

The T2DM group had a 12.61% lower geometric mean AFP level than the healthy control group (2.08 vs. 2.38 μg/L, P < 0.001). Of 501 HCC patients, 230 (45.91%) had T2DM. When compared to the HCC+NDM group, the HCC+DM group had a higher negative rate of AFP (55.22% vs. 37.26%, P < 0.001), worse liver function (P = 0.011) and a 64.87% lower geometric mean AFP level (25.71 vs. 73.18 μg/L, P < 0.001). T2DM was significantly associated with the risk of high-grade (grade 3 and 4) HCC (OR = 2.02, 95% CI 1.18-3.44, P = 0.010).

CONCLUSIONS

T2DM was associated with lower AFP level, worse liver function and higher risk of high-grade HCC. We speculated that low AFP levels in diabetics might delay and interfere with HCC diagnosis, leading to higher degree of malignant HCC.

摘要

目的

探讨 2 型糖尿病(T2DM)与肝细胞癌(HCC)和甲胎蛋白(AFP)的关系。

方法

本研究纳入了 750 例 T2DM 患者(T2DM 组)、800 例健康对照者(对照组)和 501 例新诊断为 HCC 的患者,这些患者均于 2010 年至 2016 年期间入组。将 HCC 患者进一步分为合并 T2DM 的 HCC 患者(HCC+DM 组)和不合并糖尿病的 HCC 患者(HCC+NDM 组)。

结果

与对照组相比,T2DM 组的 AFP 几何均数低 12.61%(2.08 vs. 2.38μg/L,P<0.001)。在 501 例 HCC 患者中,有 230 例(45.91%)合并 T2DM。与 HCC+NDM 组相比,HCC+DM 组的 AFP 阴性率更高(55.22% vs. 37.26%,P<0.001),肝功能更差(P=0.011),且 AFP 几何均数更低(25.71 vs. 73.18μg/L,P<0.001)。T2DM 与高级别(3 级和 4 级)HCC 的发病风险显著相关(OR=2.02,95%CI 1.18-3.44,P=0.010)。

结论

T2DM 与 AFP 水平较低、肝功能较差和高级别 HCC 的风险增加相关。我们推测,糖尿病患者 AFP 水平较低可能会延迟和干扰 HCC 的诊断,导致更恶性的 HCC。

相似文献

1
Lower alpha fetoprotein and higher risk of hepatocellular carcinoma, study from the type 2 diabetes mellitus patients.甲胎蛋白低值和肝癌风险升高,来自 2 型糖尿病患者的研究。
Diabetes Res Clin Pract. 2018 Sep;143:239-244. doi: 10.1016/j.diabres.2018.07.018. Epub 2018 Jul 31.
2
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.豆凝集素反应性甲胎蛋白在肝细胞癌诊断中的效用:在美国转诊人群中的评估
Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267. doi: 10.1016/j.cgh.2006.12.005.
3
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.甲胎蛋白-L3血清学阳性的肝内胆管癌患者以及肝细胞癌合并胆管癌患者的临床病理特征
J Gastroenterol Hepatol. 2006 May;21(5):869-73. doi: 10.1111/j.1440-1746.2006.04257.x.
4
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.PNPLA3和JAZF1对2型糖尿病非病毒性肝炎患者肝细胞癌的影响
J Gastroenterol. 2016 Apr;51(4):370-9. doi: 10.1007/s00535-015-1116-6. Epub 2015 Sep 3.
5
Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.联合血清肝癌特异性甲胎蛋白与循环甲胎蛋白信使核糖核酸在肝细胞癌诊断中的应用
Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):538-44.
6
Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.肿瘤相关自身抗体在甲胎蛋白阴性肝细胞癌的免疫诊断中具有重要的应用价值。
World J Gastroenterol. 2017 May 21;23(19):3496-3504. doi: 10.3748/wjg.v23.i19.3496.
7
Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.肝硬化严重程度与肝细胞癌中 2 型糖尿病的关系。
Exp Biol Med (Maywood). 2018 Feb;243(4):323-326. doi: 10.1177/1535370217744511. Epub 2017 Nov 29.
8
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.甲胎蛋白对豌豆凝集素的反应在良性肝病与肝细胞癌鉴别诊断中的应用
Chin Med J (Engl). 1993 Aug;106(8):615-8.
9
[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].α-甲胎蛋白在肝细胞癌诊断中的应用
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):440-3.
10
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.治疗中甲胎蛋白是接受恩替卡韦治疗的慢性乙型肝炎患者肝细胞癌的特异性肿瘤标志物。
Hepatology. 2014 Mar;59(3):986-95. doi: 10.1002/hep.26739. Epub 2014 Jan 30.

引用本文的文献

1
Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis.AKR1B10 在肝细胞癌中的临床价值:系统评价和荟萃分析。
PLoS One. 2022 Dec 30;17(12):e0279591. doi: 10.1371/journal.pone.0279591. eCollection 2022.
2
Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.循环肿瘤细胞在肝细胞癌(HCC)诊断和预后中的临床价值:一项系统评价和荟萃分析
Medicine (Baltimore). 2020 Oct 2;99(40):e22242. doi: 10.1097/MD.0000000000022242.